OSOlga Viktorovna Sharapova

Olga Viktorovna Sharapova

*This is an algorithmically generated author record based on publicly available information.

Olga Viktorovna Sharapova has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Morphological and molecular features of decidual endometrial cells in miscarriage

    by Tatiana Anatolyevna Gusarova, Natalia Victorovna Nizyaeva, Sergey Alexandrovich Mikhalev, Natalya Borisovna Tikhonova, Darya Alexandrovna Orgadeeva, Liudmila M. Mikhaleva, Olga Viktorovna Sharapova, Низяева Наталья Викторовна, Михалев Сергей Александрович, Михалева Людмила Михайловна

    Decidualization is a dynamic, multistep process that results in the differentiation of elongated endometrial stromal cells into round, epithelioid-like decidual cells in response to increasing progesterone levels. Throughout pregnancy, decidual stromal cells play an important role by creating a tolerant microenvironment, the decidua, to suppress the maternal immune response and prevent rejection of the allogeneic fetus. Decidualization is considered significant not only in the establishment and maintenance of pregnancy, prevention of early losses, and modulation of the immune response but also in the control of the onset of labor, regulation of trophoblast invasion, and embryo selection. Decidual cells have immunomodulatory properties in relation to cells of innate and adaptive immunity. Pregnancy maintenance requires selective elimination of proinflammatory senescent decidual cells by activated uterine natural killer cells. Data on various populations of decidualizing endometrial stromal cells revealed subtypes with different functional characteristics, namely, predecidual, decidual, transitional, and senescent subpopulations. An increase in the number of the latter with a proinflammatory phenotype leads to miscarriages. This paper analyzes the literature data on decidualization and its role in the genesis of miscarriage and highlights the contribution of decidual stromal cells to the microenvironment and their direct or indirect influence on the recruitment, distribution, and function of immune cells, extracellular matrix remodeling, and placenta formation.


  • Open Access

    Treating Rheumatoid Arthritis by Genetically Engineered Biological Drugs: A Case Study.

    by Zhuravleva Nadezhda Vladimirovna, Sharapova Olga Viktorovna, Gerasimova Liudmila Ivanovna, Diomidova Valentina Nikolaevna, Smirnova Tatiana Lvovna, Ukhterova Nadezhda Dmitrievna, Karzakova Luiza Michailovna, Arkhipova Anastasia Vladimirovna, Yastrebova Svetlana Alexandrovna

    The current modern treatment for Rheumatoid Arthritis is the genetically engineered biological drug rituximab. This drug helps to low the active rheumatoid arthritis. The aim of the study is to find and evaluate the clinical efficacy of rituximab . We present our own clinical observation of rituximab use in RA treatment of a female patient. We made the clinical assessment of the patient's condition with the use of clinical, laboratory and instrumental methods. We made diagnostics with the use of the ACR/EULAR (American College of Rheumatology/European Alliance of Associations for Rheumatology) criteria. ESR, concentration of C-reactive protein, IgM of rheumatoid factor, antibodies to cyclic citrullinated peptide were determined. In 2007 the patient was diagnosed RA. She received the treatment with methotrexate, metipred, sulfasalazine, dexamethasone, cyclophosphamide, leflunomide, diprospan, non-steroidal anti-inflammatory drugs (NSAIDs). There was no effect. She had the total right & left knee joints arthroplasty. In 2009, according to blood tests she had: ESR according to Westegren is 90 mm/h, antibodies to cyclic citrulline-containing peptide (AB-CCP) is 500 U/ml, CRP 121.3 mg/l, RF 125.7 IU / ml. She had the diagnosis of rheumatoid arthritis, seropositive, grade 3 activity according to the DAS activity index 28 = 6.11 points with extra-articular manifestations (rheumatoid nodules) late stage, erosive (radiologically stage III), AB-CCP (+), FTS III. She started to receive rituximab therapy. Due to the durable inflammation, the secondary amyloidosis has started. At the same time the secondary systematic osteoporosis has started. We continued the rituximab therapy & zolendronic acid. The RA activity was low (according to the DAS index 28 = 2.95 points). In our study we found that the genetically engineered biological preparation (GEBP) rituximab is effective in the rheumatoid arthritis modern therapy.


  • Open Access

    Map analysis of morbidity and mortality from blood circulatory system diseases of the population of the Russian federation (2010-2019)

    by O. V. Sharapova, D. I. Kicha, L. I. Gerasimova, O. V. Rukodaynyy, R. V. Fomina, A. V. Evzerikhina, E. V. Barsukova

    Highlights. For the first time, mapping models of morbidity and mortality from the blood circulation system diseases for assessing the performance of the health protection system in federal districts of the Russian Federation were proposed. The method makes it possible to identify low-quality health systems, and outsider regions, where it is necessary to develop measures in order to identify modifiable and non-modifiable risk factors and improve the performance of health care system both in federal districts and in the Russian Federation as a whole.Aim. To develop mapping models of morbidity and mortality from the blood circulation system diseases (BCSD) and to propose indices for assessing the performance of the health care system in different federal districts of Russia over a 10-year period (from 2010 to 2019).Methods. Reporting forms of federal statistical observation in the field of public health were used.Results. The incidence of BCSD among the population of the Russian Federation has been steadily increasing over the past two decades, increasing 2.047-fold from 2000 to 2019, while the mortality rate of the Russian population decreased 2.073-fold over the same period. Mapping models of morbidity and mortality from BCSD have been developed and indices for assessing the performance of the health protection system in different federal districts of Russia over a 10-year period (from 2010 to 2019) have been proposed.Conclusion. The mapping of low and ultra-low incidence rates of BCSD combined with high and ultra-high mortality rates from BSC among the population of the federal districts indicates low detection rates and low performance of the primary health care system in detecting BSC among the population assigned to receive primary health care according to the territorial principle. The correlation of indicators of general morbidity and mortality from HIPC in relation to health care resources allows timely assessment and finding resources in those areas that contribute to the maximum efficiency of medical organizations at minimum cost.


  • The profile of the patient to be ready to use digital technologies and Artificial Intelligence methods when receiving medical care

    by Yulia S. Reshetnikova, Olga V. Sharapova, Alla L. Katkova, Olga A. Nesterova, Natalia S. Brynza, Ivan M. Petrov

    Introduction. During the COVID-19 pandemic, there was quarantine, limited contacts, and an increased burden on the healthcare system in the last two years. These problems have led to a rethinking and transformation of patients’ readiness for the digitalisation of healthcare. Purpose. to form a patient profile, ready to use digital technologies and artificial intelligence methods in medical care during the COVID-19 pandemic, based on technological competence and digital literacy skills analysis. Material and methods. The sociological survey of patients was used through the remote distribution of links to the Google form on the Internet. The survey consists of 11 blocks, including an assessment of attitudes towards digital technologies and artificial intelligence in healthcare. Results. The average age of respondents was 41.8 ± 0.7 years, mostly female 225 (74%) in the group of patients ready to use electronic wearable devices to monitor and control their health. One hundred thirty-one people (43.1 %) regularly monitor their blood pressure levels. One hundred thirty-seven people (45%) assess their health as good and 133 (43.7%) satisfactory. 256 (84.2%) respondents mostly work full-time. Ones do physical exercises regularly in 34.2% (n = 104) cases and rarely in 48,7% (n = 148). Only 164 respondents (29.4%) consider it possible to use artificial intelligence methods in providing medical care, preventing the development of diseases and promoting a healthy lifestyle, against 256 people (45.9%), the remaining 137 people (24.6%) found it difficult to answer. Women (49.7%) were more often against artificial intelligence methods than men (33.6%). Conclusion. It is necessary to consider the patient’s profile characteristics, who is ready to use digital technologies and artificial intelligence methods in medical care when developing effective programs to increase the level and pace of healthcare’s digitalisation in the region.


  • SAFETY ASPECTS OF TREATMENT WITH GLUCOCORTICOIDS IN RHEUMATOID ARTHRITIS

    by N.V. Zhuravleva, O.V. Sharapova, Liudmila I. Gerasimova, T.L. Smirnova, V.N. Diomidova, A.V. Arkhipova


  • Quality of prevention in the structure quality of care

    by O.V. Sharapova, D.I. Kicha, O.V. Rukodaynyy, Liudmila I. Gerasimova, N.M. Zakharchenko, D.F. Moroga, R.V. Fomina


  • Open Access

    Improvement of institutions for dispensary observation of children from the risk group in phthisiology

    by Olga V. Sharapova, Natalya S. Brynza, Dmitry I. Kicha, Людмила Ивановна Герасимова, Daria M. Slashcheva, Natalia D. Pirogova, Antonina D. Petrushina

    Introduction. Tuberculosis in Russia is one of the primary problems of epidemiology and public health. The purpose: to analyze the epidemic situation of tuberculosis in high-risk groups of children and adolescents in the Tyumen region of Russia. Material and methods. Were analyzed the annual reporting forms No. 33 «Information about patients with tuberculosis» for 2014-2018 in the Tyumen region. Results. According to our research, research materials in the region, WHO recommendations for eliminating tuberculosis by 2035 the need to develop new approaches and practical recommendations for clinical dispensary observation of children with altered tuberculin sensitivity is justified. Discussion. The epidemic situation among children with altered tuberculin sensitivity by 2018 in the districts of the Tyumen region is characterizing by its heterogeneity. In some districts of the region, the number of children with a turn of tuberculin reactions remains high or continues to increase. Such trends can be associated with the incidence of tuberculosis and the presence of patients with open forms of respiratory tuberculosis in these areas. Conclusion. To improve the efficiency of preventing the development of active tuberculosis in Russian children in 2010, a mathematical model of immune response developed in the Tyumen Region based on the study of immunological indices in groups of children with high sensitivity and hyperresponsiveness to the Mantoux tests 2TE samples. The model can be successfully used for diagnostics and assess the characteristics of the course of tuberculosis infection.